InsidersTradesSigma
Follow the INVION LIMITED stock price and the full insider trade history of the company, a listed equity based in Australia. Shares trade on AU AU, under the supervision of ASX. Market capitalisation: €3.5m. The latest transaction was disclosed on 19 June 2026 (Purchase). Among the most active insiders: Alistair Bennallack. All data is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
INVION LIMITED is an Australian Securities Exchange listed company focused on developing innovative cancer treatments. It specializes in using nanomedicine technology to enhance patient outcomes.